Science Market Update

CU Boulder Research: $1.1M For Next-Generation Vaccine Development

Posted by Emily Olson on Fri, Nov 18, 2016

Researchers at the University of Colorado Boulder have received a $1.1 million grant from the Bill & Melinda Gates Foundation to support development of next-generation vaccines. If the project is successful, these new vaccines will be able to defend against diseases with just one shot and won't need to be refrigerated. These improvements could have an immense impact on the difficult challenge of dispensing life-saving immunizations. 

Read More

Tags: University of Colorado, vaccine, new research funding, vaccine research, University of Colorado Boulder, Colorado, new research grant

Stony Brook Lyme Disease Vaccine Shows Promise in Clinical Trials

Posted by Jennifer Nieuwkerk on Mon, Aug 26, 2013

Clinical trials were recently conducted and proved promising for a Lyme Disease vaccine developed by science researchers at Stony Brook University. The vaccine proved to produce a large number of antibodies against all targeted species of Borrelia, which causes Lyme Disease in Europe and the United States. Baxter International S.A., who worked with Stony Brook University researchers to develop the vaccine, conducted the clinical trials.

Read More

Tags: 2014, 2013, Northeast, Lyme Disease, vaccine, New York, Stony Brook University, BioResearch Product Faire Event, NY, Stony Brook, research news, SunySB

Subscribe to Company News